scispace - formally typeset
A

Alireza Heidari

Researcher at Golestan University

Publications -  52
Citations -  331

Alireza Heidari is an academic researcher from Golestan University. The author has contributed to research in topics: Health care & Population. The author has an hindex of 9, co-authored 47 publications receiving 259 citations. Previous affiliations of Alireza Heidari include Tehran University of Medical Sciences.

Papers
More filters
Journal ArticleDOI

Effectiveness of Methadone Maintenance Treatment in Prevention of Hepatitis C Virus Transmission among Injecting Drug Users

TL;DR: The MMT program is an effective intervention to prevent HCV infection transmission, although it is essential to compare its effectiveness with other interventions before implementing it in nationwide.
Journal Article

Concept and Challenges of Delivering Preventive and Care Services in Prehospital Emergency Medical Service: A Qualitative Study

TL;DR: To enhance and promote services, the EMS system of Golestan province need reforms in organizational structure, laws and administrative regulations, training programs, the system of monitoring and evaluation of personnel, also provision of equipment and manpower and provision of personnel amenities to improve the staff performance.
Journal ArticleDOI

Survey of natural disasters preparedness in public and private hospitals of Islamic republic of Iran (case study of shiraz, 2011)

TL;DR: Although the disaster preparedness in the study hospitals was good, they were not well prepared in some domains, such as evacuation and transfer, traffic, communication, and security; therefore, plans are needed to be developed in these regards.
Journal ArticleDOI

Cost-effectiveness of Methadone Maintenance Treatment in Prevention of HIV Among Drug Users in Shiraz, South of Iran

TL;DR: Establishment of MMT centers in regional and national levels seems reasonable and the results of the sensitivity analysis indicated that MMT intervention was cost-effective even in the worst scenario and ICER varied from $ 39149 to $ 290004 per HIV case averted.